albuterol has been researched along with Consciousness, Loss of in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dimond, JP | 1 |
Palazzo, MG | 1 |
Löwhagen, O | 1 |
Ekström, L | 1 |
Holmberg, S | 1 |
Wennerblom, B | 1 |
Rosenfeldt, M | 1 |
2 other studies available for albuterol and Consciousness, Loss of
Article | Year |
---|---|
An unconscious man with asthma and a fixed, dilated pupil.
Topics: Albuterol; Asthma; Brain Edema; Bronchodilator Agents; Carbon Dioxide; Humans; Hypoxia; Intracranial | 1997 |
Experience of an emergency mobile asthma treatment programme.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Albuterol; Ambulances; Asthma; Broncho | 1997 |